Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Manyun Long"'
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-16 (2020)
Abstract Background In this meta-analysis, we aimed to systematically compare the post percutaneous coronary interventional (PCI) adverse bleeding events, stent thrombosis, stroke and other cardiovascular outcomes in a population of patients with and
Externí odkaz:
https://doaj.org/article/a438e3c02d8c421aafa10bfb456c9be0
Publikováno v:
Cardiology Plus, Vol 4, Iss 3, Pp 91-96 (2019)
Background: Coronary microembolization (CME) is a severe complication in the treatment of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). It is a distal microvascular embolism caused by the shedding of atherosclerotic plaq
Externí odkaz:
https://doaj.org/article/1d59bf7230f248b18ce7199c3a0878f9
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract Cardiomyocyte apoptosis is a key factor in the deterioration of cardiac function after coronary microembolization (CME). Nicorandil (NIC) affects myocardial injury, which may be related to the inhibition of apoptosis. However, the specific m
Externí odkaz:
https://doaj.org/article/638672d0628a4d5ab05556d13740b583
Publikováno v:
Cardiology Plus, Vol 4, Iss 3, Pp 91-96 (2019)
Background: Coronary microembolization (CME) is a severe complication in the treatment of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). It is a distal microvascular embolism caused by the shedding of atherosclerotic plaq
Publikováno v:
European Heart Journal. 40:e1-e10
Aims Whether a loading dose of atorvastatin (80 mg) can reduce major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) remains controversial. Therefore, we performed this meta-analysis. Methods and results Randomized
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-16 (2020)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background In this meta-analysis, we aimed to systematically compare the post percutaneous coronary interventional (PCI) adverse bleeding events, stent thrombosis, stroke and other cardiovascular outcomes in a population of patients with and without
Autor:
Manyun Long, Lang Li
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND This study aimed to investigate the association between serum levels of cystatin C, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and cardiac function in patients with unstable angina pectoris (UAP). MATERIAL AND METHODS A cross-s
Publikováno v:
Drug Design, Development and Therapy
Ziliang Ye,1 Haili Lu,2 Qiang Su,1 Manyun Long,1 Lang Li1 On behalf of the PENMIPCI investigators 1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China; 2Department of O
Publikováno v:
Disease Markers, Vol 2018 (2018)
Disease Markers
Disease Markers
Background. Whether serum uric acid (UA) is associated with all-cause mortality in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI) remains unclear. Methods. We performed a retrospective cohort study of 2
Publikováno v:
Circulation. 139:1467-1468